Ó³»­´«Ã½

A study testing thousands of medicines in hundreds of cancer cell lines in the lab uncovers new tricks for many old drugs

Study will help narrow down the list of targets for the next generation of cancer treatments

A computational model could improve the selection of tumor antigens for personalized cancer vaccines that are now in early-stage clinical trials.

The finding suggests a potentially more targeted way to treat certain patients with the disorder, called CHIP, which commonly affects the elderly

The new tool more accurately distinguishes mutations that drive cancer from ones that don’t, and could help focus future research and drug development.

A clinical study comparing liquid and tissue biopsies finds multiple resistance mechanisms in individual patients, which could explain why targeted therapies often fail.

Analysis of single glioblastoma cells shows that they can flip between four different states

Analyzing RNA sequencing data pinpoints ‘somatic clones,’ including some harboring cancer mutations, in many types of normal tissue.

By matching cells' growth trajectories to their genetic features, a team finds CLL cells' arc of growth is written into their genes early in disease development.